Safety Alerts & Recalls

Search all Safety Alerts & Recalls

Latest Alerts

Nycomed US, Inc. Recalls select lots of Fluocinonide Ointment USP, 0.05%
Nycomed US, Inc. is recalling select lots of Fluocinonide Ointment USP, 0.05%, 15 gram, 30 gram, and 60 gram tubes, for external use only. The following lots and expiration dates (exp) are being recalled as a precaution because samples from a previous batch did not pass the manufacturer's routine tests for the acceptable amount of by-products from chemical breakdown over time: Fluocinonide Ointment USP, 0.05%, 15 grams: batch 902A (exp 9/11) Fluocinonide Ointment USP, 0.05%, 30 grams: batch 982A (exp 10/11) Fluocinonide Ointment USP, 0.05%, 60 grams: batch 111B (exp 10/11) The following lot and expiration date (exp) is being recalled because of reports of leakage from the tube crimp: Fluocinonide Ointment USP, 0.05%, 30 grams: batch 872A (exp 9/11) Fluocinonide ointment is applied to the skin for the treatment of a variety of skin conditions. This recall alert only applies to select lots of Fluocinonide Ointment USP, 0.05% made by Nycomed US, Inc. No other fluocinonide products were involved in this recall. To view the FDA notice about this recall, please visit: http://www.fda.gov/downloads/Safety/Recalls/EnforcementReports/UCM207276.pdf and http://www.fda.gov/Safety/Recalls/EnforcementReports/ucm207761.htm
Learn More

Amoxicillin and Clavulanate Potassium for Oral Suspension: Recall by Ranbaxy
Ranbaxy Pharmaceuticals, Inc. is recalling two lots of Amoxicillin and Clavulanate Potassium for Oral Suspension, 400 mg/5 mL. Lot numbers 1910779 and 1910782 are being recalled because the company received complaints that the suspension (a liquid form of the antibiotic) turned brown. The product should be white. Amoxicillin and Clavulanate Potassium is an antibiotic used to treat infections. Amoxicillin and Clavulanate Potassium is also sold under the brand name Augmentin. This recall alert only applies to the two lots of the generic Amoxicillin and Clavulanate Potassium for Oral Suspension, 400 mg/5 mL. made by Ranbaxy. No other products were involved in this recall. To view the FDA notice about this recall, please visit: http://www.fda.gov/Safety/Recalls/EnforcementReports/ucm207761.htm
Learn More

Date Published Title Drug Source
2010-04-12 Nycomed US, Inc. Recalls select lots of Fluocinonide Ointment USP, 0.05% Fluocinonide FDA
2010-04-12 Amoxicillin and Clavulanate Potassium for Oral Suspension: Recall by Ranbaxy Amoxicillin Sodium with Clavulanate Potassium FDA
2010-04-08 Recall of Our Family Ibuprofen Caplets 200 mg FDA
2010-04-02 Recall of Four Lots of Humira Pen Psoriasis Starter Package Adalimumab FDA
2010-04-02 Lannett Co., Inc Recalls Select Lots of Dipyridamole 25 mg Tablets Dipyridamole FDA
2010-04-02 Non-Safety-Related Recall of a Limited Portion of Daytrana Patches Methylphenidate Manufacturer
2010-04-01 Clear Nicotine Patch 7 mg Recalled At Warehouse/Retail Level Nicotine FDA
2010-04-01 Ongoing Recall Of Single Lot of Glyburide and Metformin 2.5 mg/500 mg Tablets FDA
2010-03-31 Schering Recalls Several Lots of Intron A FDA
2010-03-31 Recall of a Single Lot of Claravis (isotretinoin) capsules, 40 mg Isotretinoin FDA
2010-03-31 Recall on a Single Lot of Ranitidine Tablets, 150 mg Ranitidine FDA
2010-03-31 Rugby Laboratories Recalls Select Lots of Children's Nasal Decongestant Liquid Pseudoephedrine FDA
2010-03-31 Cadista Recalls Single Lot of Prednisone 1 mg Tablets Prednisone FDA
2010-03-31 The FDA Issues Drug Safety Communication: Ongoing Safety Review of Stalevo and Possible Development of Prostate Cancer Entacapone FDA
2010-03-23 Eli Lilly and Company Publishes Notification of Stolen Products Fluoxetine with Olanzapine Manufacturer
2010-03-19 FDA: Ongoing Safety Review of High-Dose Simvastatin (Zocor) and Increased Risk of Muscle Injury Simvastatin FDA
2010-03-17 FDA Warns Companies to Stop Producing Unapproved Nitroglycerin Nitroglycerin FDA
2010-03-16 Recall of Several Brands of Diphenhydramine HCL 25 mg Capsules Diphenhydramine FDA
2010-03-16 Cadista Has Completed Its Recall Of Terazosin 5 mg Capsules Terazosin FDA
2010-03-16 Novartis Issues Recall Of Single Lot of Amlodipine/Benazepril Capsules at Warehouse/Retail Level FDA
Back to Consumer Med Safety